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The matrix metalloproteinase (MMP) family is involved in the breakdown of extracellular matrix in normal physiological
processes, as well as in the disease processes such as arthritis and cancer metastasis. In the present study, dieckol was obtained
with high yield from marine brown alga Ecklonia cava (EC), and its eﬀect was assessed on the expression of MMP-2 and -9 and
morphological changes in human ﬁbrosarcoma cell line (HT1080). Dieckol inhibited the expression of MMP-2 and -9 in a dose-
dependentmannerandalsosuppressedthecellinvasionandthecytomorphologyin3DculturesystemonHT1080cells.Moreover,
dieckol may inﬂuence nuclear factor kappa B (NF-κB) pathway without obvious inﬂuence on activator protein-1 (AP-1) pathway
and tissue inhibitor of metalloproteinases (TIMPs). In conclusion, dieckol could signiﬁcantly suppress MMP-2 and -9 expression
and alter cytomorphology of HT1080 cell line via NF-κBp a t h w a y .
1.Introduction
The past few decades of cancer research has revealed that
matrix metalloproteinases (MMPs) play a signiﬁcant role in
a variety of pathologic conditions. Especially in malignant
tumors, the activities of MMPs are deregulated and their
expressionsareoftenassociatedwithpoorprognosis.Among
all the MMPs, MMP-2 and -9 have demonstrated to play
a major role in the establishment of metastasis, which
substantially increases in majority of malignant tumors.
Therefore, inhibition of MMP-2 and -9 is thought to have
a therapeutic beneﬁt for cancer [1–8].
Recently, signiﬁcant achievements have been made in
synthetic bioactive applications. However, natural com-
pounds and their derivatives are still known as the richest
source of bioactive compounds with huge pharmaceutical
application potential [9]. Dieckol (Figure 1) is a phloroglu-
cinal derivative isolated from marine brown alga Ecklonia
cava (EC) with a variety of biological functions in vitro
and in vivo, for example, antioxidant, antitumor, antihuman
immunodeﬁciency virus (-HIV), and anti-inﬂammatory
activities. For instance, dieckol is a novel safe phloroglucinal
derivative which inhibited the cytopathic eﬀects of HIV-1
including HIV-1-induced syncytia formation, lytic eﬀects,
and viral p24 antigen production, as well as exhibited reverse
transcriptase enzymes inhibitory and HIV-1 entry activity in
addition to its other biological properties [10, 11].
In the present study, eﬀect of dieckol on the expression
of MMP-2 and -9, cytotoxicity, and cellular invasiveness was
evaluated in HT1080 cells. The selectivity of this cell line
was based on the extensive studies performed previously
on MMPs expression [12]. In addition, the mechanism
of dieckol regulating MMP-2 and -9 via the inﬂuence on
nuclear factor kappa B (NF-κB) pathway has also been
investigated.
2.MaterialsandMethods
2.1. General Materials. 1H NMR (400MHz) and 13CN M R
(100MHz) spectra were recorded on a JEOL JNM-ECP2 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Chemical structure of dieckol.
400 NMR spectrometer (JEOL, Japan), using DMSO-d6
solvent peak (2.50ppm in 1H and 39.5ppm in 13CN M R )
as an internal reference standard. For some signals, the
chemical shifts approximated at the third decimal place.
This is to distinguish between signals of very close value,
but which could nevertheless be clearly diﬀerentiated by
visual inspection of the spectra. MS spectra were obtained
on a JEOL JMS-700 spectrometer (JEOL, Japan). Extraction
of EC was performed using extraction unit (Dongwon
Scientiﬁc Co., Republic of Korea). Column chromatography
was carried out by silica gel 60 (230–400 mesh, Merck, Ger-
many) and Sephadex LH-20 (Sigma, St. Louis, Mo). Thin-
layer chromatography (TLC) was run on precoated Merck
Kieselgel 60 F254 plates (0.25mm), and the spots on the TLC
plate were detected under UV lamp (254 and 365nm) using
CHCl3/MeOH/H2O/acetic acid (65:25:4:3, v/v/v/v) as a
development solvent system. Vanillin-H2SO4 was employed
as the detecting agent for phenolic compounds. All the
solvent and chemicals used in this study were of reagent
grade from commercial sources (Duksan Pure Chemicals
Co., Ltd., Republic of Korea).
2.2. Extraction, Isolation, Puriﬁcation, and Elucidation of
Dieckol. Ecklonia cava was collected from Jeju Island coast
of Republic of Korea, washed three times with water to
remove salt, and subjected to lyophilization. The lyophilized
EC was ground into powder before extraction. The dried EC
powder (10kg) was extracted by stirring extraction unit with
MeOH (3 × 5L) for 10 days at room temperature (25◦C).
The extract (273g) was suspended in water and partitioned
with n-hexane (35.92g), CH2Cl2 (20.49g), EtOAc (24.87g),
and n-BuOH (106g) in a sequence. The EtOAc fraction
(24.87g) was subjected to a silica gel ﬂash chromatography
eluted with Hexane/EtOAc/MeOH/CH2Cl2 (gradient) to
yield ten subfractions (F1–F10). The F5 subfraction was
further puriﬁed by Sephadex LH-20 with MeOH obtained
dieckol (58.30mg).
2.3. Cell Culture and Cell Viability Assay. Human ﬁbrosar-
coma cells (HT1080) from ATCC were cultured in Dul-
becco’s Modiﬁed Eagle’s Medium (DMEM), supplemented
with 10% fetal bovine serum (FBS), 2mM glutamine, and
100U/mLpenicillin-streptomycin,andincubatedat5%CO2
and 37◦C humidiﬁed atmosphere. For experiments, cells
were passaged at least for 5 times and detached with Trypsin-
EDTA. For cell viability assay, cells were seeded in 96-well
plates at a density of 1 × 104 cells/well in 200μLD M E M
containing 10% fetal bovine serum. After 24 hours, the
medium was removed and the cells were incubated for
48h with DMEM containing 1% FBS in the absence or
presence of various concentrations of dieckol. Forty-eight
hours later, 100μL 3-(4,5)-dimethylthiahiazol (-z-y1)-3,5-
di-phenytetrazoliumromide (MTT) (0.5mg/mL ﬁnal con-
centration)wasaddedtoeachwellandincubatedforanother
4 hours at 37◦Ci n5 %C O 2. Finally, DMSO (150μL) was
added to solubilize the formazan salt formed and amount
of formazan salt was determined by measuring the OD
at 540nm using GENios microplate reader (Tecan Austria
GmbH, Austria). Relative cell viability was determined by
the amount of MTT converted into formazan salt. Viability
of cells was quantiﬁed as a percentage compared to the
control and dose response curves were developed. The data
were expressed as mean (±SD) from three independent
experiments.
2.4. In Vitro Invasion Assay. An in vitro invasion assay
was performed using a 24-well transwell unit (8μmp o r e
size) with polyvinylpyrrolidone-free polycarbonate ﬁlters
coated with 500μg / m Lo fM a t r i g e la n dp l a c e di nt r a n s w e l l
chambers. The coated ﬁlters were washed thoroughly in
PBS and dried immediately before use. Cells were placed
in the upper part of the transwell plate and allowed cell
attachement for 24 hours, then incubated with dieckol for 36
hours at 37◦C. The cells that invaded the lower surface of the
membrane were ﬁxed with methanol and stained with 0.5%
crystal violet for 10min. Finally, we determined invasive
phenotypes by counting the cells that migrated to the lower
side of the ﬁlter using Leica DM6000B microscopy at 200 ×
(Leica Microsystems Wetzlar GmbH, Germany) in at least 5
bright ﬁelds [13].
2.5. Three-Dimensional (3D) Culture of HT1080 Cell Line.
The cells behavior and morphology in 3D culture system is
quite diﬀerent from that observed in the 2D system [14]. The
3D culture model was established as described previously
[15]. Brieﬂy, HT1080 cells (1.5 × 103)w e r es u s p e n d e dw i t h
a neutralized solution of type I collagen (1mg/mL) (Sigma,
St. Louis, Mo) and 1/5 volume of a 5 × DMEM. The
cell suspension containing various ﬁnal concentrations of
dieckol was added to 24-well plates and kept at 37◦C untilEvidence-Based Complementary and Alternative Medicine 3
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Figure 2: Eﬀect of dieckol on the viability of HT1080 cells. Data
represented as mean ± SD of three independent experiments.
gelled. The plates were then incubated at 37◦C for 24 hours.
The results were observed under microscope at 200 × (Leica
Microsystems Wetzlar GmbH, Germany).
2.6. Gelatin Zymography. For gelatin zymography, HT1080
cells were seeded in 24-well plates using serum-free media
and pretreated with diﬀerent concentrations of dieckol
for 1 hour. MMP expression was stimulated by 12-O-
tetradecanoylphorbol 13-acetate (PMA) (10ng/mL) and
incubation was continued for 48 hours. After incubation,
conditioned media were collected and their protein con-
tents were determined by the Bradford method [16]. After
normalizing the protein content, equal amounts of proteins
were electrophoresed under nonreducing conditions on 10%
polyacrylamide gels containing 1.5mg/mL gelatin. Follow-
ing electrophoresis, polyacrylamide gels were washed with
50mM Tris-HCl (pH 7.5) containing 2.5% Triton X-100 to
remove sodium dodecyl sulfate. Gels were then incubated
overnight at 37◦C in a developing buﬀer containing 10mM
CaCl2, 50mM Tris-HCl, and 150mM NaCl to digest gelatin
by MMPs. Areas of gelatin hydrolyzed by MMPs were visu-
alized as clear zones against blue background by Coomassie
blue staining and the intensities of the bands were estimated
by densitometry (Multi Gauge V3.0 software, Fujiﬁlm Life
Science, Japan) [12].
2.7.ReverseTranscription-PCR. TotalRNAfromeachsample
was isolated by TRIzol reagent and subjected for reverse
transcription-PCR (RT-PCR). For RT-PCR analysis, total
RNA was reverse-transcribed to synthesize cDNA using a
commercial kit (TaKaRa RNA PCR kit (AMV)) according
to the manufacturer’s protocol. PCR was then carried out
in 50μL of reaction volumes containing RNA PCR buﬀer,
2.5mM MgCl2,0 . 2 μM of each primer, and 2.5 units of
TaKaRa Taq polymerase. Samples were predenatured at 94◦C
for 4min, followed by ampliﬁcation at 94◦C for 1min, at
55◦Cf o r3 0s ,a n da t7 2 ◦C for 1min for 25 cycles, followed
by a ﬁnal 10min extension step at 72◦C. The primers for
GAPDH were 5 -GTCAACGGATTTGGTCGTATT-3   and
5 -AGTCTTCTGGGTGGCAGTGAT-3  with an expected
ampliﬁed product of 300bp. The MMP-2 primers were 5 -
CTCAGATCCGTGGTGAGATCT-3  and 5 -CT TTGGT-
TCTCCAGCTTCAGG-3 with an expected ampliﬁed prod-
uct of 496bp. The MMP-9 primers were 5 -ATCCAGTTT-
GGTGTCGCGGAGC-3  and 5 -GAAGGGGAAGACGCA-
CA GCT-3  with an expected ampliﬁed product of 552bp.
2.8. Extraction of Nuclear and Plasma Proteins and Western
Blot Analysis. HT1080 cells were pretreated without or with
diﬀerent concentrations of dieckol for 1 hour followed by the
stimulation with PMA, and the incubation was continued
for another 48 hours. For separate extraction of nuclear and
cytoplasm proteins, CelLytic NuCLEAR Extraction kit (S26-
36-23, Sigma-Aldrich Co., Mo, USA) was used by following
manufacturer’sinstructions.Thecellswerelysedwith0.5mL
of lysis buﬀer (500μL hypotonic lysis buﬀer, 5μL0 . 1 M
dithiothreitol (DTT), and 5μL protease inhibitor cocktail,
proteasome inhibitor, MG132) for 15min on the ice. Igepal
CA-630 solution (4μL) was added and vortexed for 20s.
nuclei were separated by centrifugation at 10,000×gf o r
10 min and supernatant (cytoplasm protein) was collected.
Precipitated nuclei were lysed with 100μLo fe x t r a c t i o n
buﬀer mix (98μLo fe x t r a c t i o nb u ﬀer, 1μL of 0.1M, DTT
and 1μL of protease inhibitor cocktail) for 10min and
nuclei protein were collected by centrifugation at 12,000×g
for 10min. Proteins were separated by 12% SDS-PAGE
and electrotransferred onto PVDF membranes (Millipore,
Bedford, Mass). After blocking with 5% skim milk in PBST
(PBS, pH 7.6, containing 0.2% Tween-20), the membranes
incubated with primary antibody (Santa Cruz Biotechnol-
ogy, Inc. us). for 1 hours, washed with 0.2% Tween-20 in
PBS, and then incubated with horseradish peroxidase-linked
secondary antibody (Santa Cruz Biotechnology, Inc., Calif,
USA). The reactive signals were visualized by ECL kit (PE
Applied Biosystems).
2.9. Statistical Analysis. All the experiments were repeated at
least three times. All results were expressed as the mean of
three replicates determination and standard deviation (SD).
Statistical comparisons were made with Student’s t-test and
P values < 0.05 were considered to be signiﬁcant.
3. Results
3.1. Cell Viability Assay. Cell viability assay was introduced
for determining whether dieckol can have toxic eﬀect
on HT1080 cells at high concentration. Comparison of
cell growth over 48h with various dieckol concentrations
(0–250μM) were showed in Figure 2.T h ev a l u e sf o ra l l
concentrations were similar with control (dieckol 0μM)
indicating that dieckol does not aﬀect cell viability below the
concentrations of 200μM.
3.2. Transwell Invasion Assay. Although no cytotoxic eﬀect
was observed even below 200μM concentration of dieckol
on HT1080 cell line, ideally, 0 to 100μM of dieckol was4 Evidence-Based Complementary and Alternative Medicine
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Figure 3: Eﬀect of dieckol on invasion in HT1080 cells. (a) Microphotographs of ﬁlters of the Matrigel chamber invasion assay. Inset
(a) represents the conclusive data of cellular invasion. (b) Dieckol Eﬀect on the morphology of HT1080 cells in three-dimensional (3D)
cultures system. The data presented are mean ± SD of three independent experiments. Values are compared with the 0μM dieckol, which
are signiﬁcant at ∗P<0.05 and ∗∗P<0.01.
used in the cell invasion and the subsequent experiments. To
investigatewhetherdieckolinhibitstumorinvasion,Matrigel
invasion assays were performed for dieckol-treated HT1080
cells. It was observed that dieckol treatment reduced the cell
invasion, and 100μM of dieckol concentration signiﬁcantly
blocked tumor invasion (Figure 3(a))[ 13, 17].
3.3. Eﬀects of Dieckol on the 3D Culture in HT1080 Cell Line.
Toinvestigatetheeﬀectofdieckolonthe3Dculturesystemof
HT1080cells,samedensityofcellswereseededinto3Dcolla-
gen gel with various ﬁnal concentrations of the dieckol. After
36h, the control (without dieckol) stretched out in the gel
a n df o r m e dm a n yb r a n c h e da n de l o n g a t e ds t r u c t u r e si nt yp e
Ic o l l a g e nm a t r i x( Figure 3(b)). In contrast, the branches
were reduced in the cells treated with 5μM concentration
of dieckol. As the concentration increased to 100μM, these
branches disappeared and cells changed to spherical shape.Evidence-Based Complementary and Alternative Medicine 5
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Figure 5: Eﬀe c to fd i e c k o lo nt h eN F - κB and AP-1 cell signaling
pathway and TIMP-1, -2 expressions in HT1080 cells. (a) Nucleus
NF-κB (p65 and p50) and IκB (p-IκB-α) protein expressions in the
dieckol treated HT1080 cells. (b) (c-jun), MAPK pathway (ERK,
JNK, p38). (c) Western blot analysis of TIMP-1 and TIMP-2.
3.4. Eﬀects of Dieckol on the MMP-2, -9 Transcription and
Expression Levels in HT1080 Cell Line. Gelatin zymography
analysis was performed, for investigating whether dieckol
couldinhibitproteinlevelsofMMP-2andMMP-9.Asshown
in Figure 4(a), protein expressions for MMP-2 and MMP-9
were signiﬁcantly inhibited by dieckol in a dose-dependent
manner. In addition, results from the RT-PCR and western
blotrevealedthattheexpressionofMMP-2and-9wasinhib-
ited at transcription levels by dieckol, more or less similar
manner with zymography analysis (Figures 4(b) and 4(c)).
3.5. Eﬀects of Dieckol Inﬂuenced AP-1, NF-κB, and IκB
Expressions on HT1080 Cell Line. Western blot studies were
carried out to assay the downregulation eﬀects of dieckol on
the possible mechanism of expression of activator protein-
1 (AP-1) and nuclear factor-kappa B (NF-κB). Meanwhile,
the tissue inhibitor of metalloproteinases (TIMP) was been
checked by western blot. As shown in Figure 5(b), dieckol
did not exhibit a clear inﬂuence of activator protein-1
(AP-1) (c-jun) expression and mitogen-activated protein
kinase (MAPK) (ERK, JNK, p38), which mediated the AP-
1. The NF-κB transcription family proteins consist of several
proteinsubunits,anditwasclearthatthelevelofNF-κB(p65
and p50) was decreased in a dose-dependent manner. The
p-IκB-α expression was increased signiﬁcantly, when treated
with high concentration of dieckol (100μM) (Figure 5(a)).
As observed in Figure 5(c), there is no distinct change in
the expressions of TIMP-1 and TIMP-2 when treated with
diﬀerent concentrations of dieckol.
4. Discussion
MMPs, a family of zinc-dependent endopeptidases, partic-
ipate in many physiological and pathological processes. An
imbalance between the inhibition and activation of MMPs
is related to some diseases such as osteoarthritis, rheuma-
toid arthritis, tumor metastasis, cardiovascular diseases and
congestive heart failure [18–20]. Finding MMP inhibitors
(MMPIs) for treatment of these prevalent diseases has been
an important aspect of present day cancer research [21].
MMPIs regulate MMPs at several biochemical pathways, but
most of them directly inhibit the activity of enzyme. Till
now, MMPIs entering clinical trial are only of synthetic
origin (organic compounds) and have failed to enter the
pharmaceutical market owing to their side eﬀects [22]. The
search for novel and natural compounds has led to the
discovery of oceans as the treasure house of substances with
amazing pharmacological potential. Therefore, discovering
the ideal MMPIs from marine natural sources is feasible and
more advantageous [23].
Ecklonia cava (a marine alga), one of the marine ﬂoral
members, produces dieckol which has been well studied
previously to inhibit the expression of various MMPs [12,
24].Inthisstudy,dieckoldidnotshowanycytotoxiceﬀecton
HT1080 cells at the concentrations below 200μM. However,
dieckol inﬂuenced the cell mobility as measured by transwell
invasion assay; it also suppressed HT1080 cells crossing the
matrix gel in a dose-dependent manner. In addition, we have
examinedtheeﬀectofdieckolontheorganizationofHT1080
c e l l si na3 Dc u l t u r ee n v i r o n m e n t .In vivo,c e l l se x p e r i e n c e
a 3D environment and are surrounded by other cells and
ECM. The traditional 2D monolayer culture system cannot
emulate the complexities of the 3D tissue microenvironment
and will always represent a suboptimal milieu for studying
physiological ECM interactions with connective tissue cells
[25, 26]. MMPs also aﬀect cell morphology in 3D culture
environment. MMPs cleave the matrix proteins ﬁbronectin,
vitronectin, and collagen I into smaller fragments. The
cleaved ECM fragments then facilitate and accelerate cancerEvidence-Based Complementary and Alternative Medicine 7
cell adhesion and invasion [15]. HT1080 cells formed the
stellate structures in the 3D culture environment, and these
structures migrated into the collagen matrix cleaving the
ECMwiththehelpoftheMMPs.However,dieckoltreatment
signiﬁcantly reduced the number and length of stellate
structures. The cultured HT1080 cells were treated with
dieckol with selected concentrations (0–200μM) and the
expression of MMP-2, -9 was induced by PMA. Several
studies have shown that PMA can induce expression of
MMP-2, -9 [27]. Dieckol inhibited the expression of MMP-
2, -9 in a dose-dependent manner, according to the results of
RT-PCR, western blot and zymography assays.
AP-1 and NF-κB are major transcription factors that
regulate MMP-2, -9 expression [28–30]. Members of the
MAPK superfamily (ERK1/2, JNKs, and p38 kinase) are
known to regulate AP-1 transactivation by increasing the
level of AP-1 components or altering the phosphorylation
of their subunits (c-jun, c-fos) and then regulate MMPs
e x p r e s s i o na n da c t i v i t yi nv a r i o u sc e l lt y p e s[ 31]. NF-κB, in
its inactive form, it is sequestered in the cytoplasm, bound by
membersoftheinhibitorofkappaB(IκB)familyofinhibitor
proteins (including IκBa, IκBb, IκBg, and IκBe). Various
stimuli that activate NF-κB result in phosphorylation of IκB,
is followed by its ubiquitination and subsequent degradation
[32, 33]. Dieckol suppress NF-κB (p65 and p50) expression
in a dose-dependent manner. However, dieckol did not
show any clear eﬀect on AP-1 and ERK1/2, JNKs, and p38
kinaseexpressions.Ithasbeenfoundthatp-IκB-αexpression
increased when treated with high concentration of dieckol
(100μM), but not in low concentration [34]. It may suggest
that the inhibitor of kappa B family could be upregulated
by high concentration of dieckol, and this may be another
reason for NF-κB suppression by dieckol. Western blot
resulted from TIMP-1 and TIMP-2 depicted that TIMP have
not been inﬂuenced by diﬀerent concentrations of dieckol. It
is indicating that inhibition of MMP-2, -9 activity by dieckol
is not because of the TIMP at the test concentrations.
At the promoter site of MMP-2 and -9 genes, several
putative binding sites for transcription factors are present,
which regulate gene expression. This promoter contains an
AP-1bindingconsensussiteat−79upstreamfromthestarter
site and further upstream, there is a cluster of regulatory
elements including another AP-1 binding site called AP-2
and NF-κB binding site [35]. It is commonly known that
MMP-9 transcription is mainly regulated via AP-1 [36, 37].
In addition to this, under some inﬂammatory and other
pathology conditions, MMP-2, -9 transcription can be reg-
ulated via NF-κB signaling pathways. Interestingly, dieckol
inhibited NF-κB expression with a similar dose-dependent
manner as observed for MMP-2, -9 expressions. However, it
did not signiﬁcantly inﬂuence the expression of AP-1. This
mode of action may be contributed to the unique chemical
structure of dieckol [38–40]. The reasons could be discussed
based on the structural features of the isolated dieckol and
the structure-activity relationship could be described due to
its unique skeleton. For example, the number of hydroxyl
groups present in its chemical structure probably plays an
important role because of the higher polymerization of
phloroglucinal units and on the other hand, the O-bridge
linkages (ether linkage) among phloroglucinals donate more
free anions to attract responsible receptors.
5. Conclusion
Dieckol was isolated from an edible marine brown alga
EckloniacavahasbeencharacterizedaccordingtotheMSand
NMR data. It acts as an inhibitor of MMP-2, -9 expressions
bythedownregulation of NF-κB pathwaywithout signiﬁcant
inﬂuence on AP-1, MAPK pathway. Furthermore, the modu-
lation of MMP-2 and -9 expressions could be one reason for
the suppression of invasiveness and 3D culturing of HT1080
cell line. Hence, this study suggested that dieckol could be an
eﬀective candidate for the suppression of cancer invasion.
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